Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
As of April 8, 2026, STAAR Surgical Company (STAA) trades at $21.09, marking a 0.62% gain from the previous closing price. The ophthalmic medical device developer has traded in a relatively tight range this month, with no major unanticipated news driving significant volatility as of this analysis. No recent earnings data is available for STAA at the time of writing, so market participants are focusing on technical levels and broader sector trends to gauge near-term price action. This analysis co
Can STAAR (STAA) Stock Go Higher | Price at $21.09, Up 0.62% - Open Stock Picks
STAA - Stock Analysis
4645 Comments
1387 Likes
1
Ziyah
Community Member
2 hours ago
I don’t know why but I feel involved.
👍 235
Reply
2
Zoela
Senior Contributor
5 hours ago
This feels like I made a decision somehow.
👍 113
Reply
3
Caydyn
Consistent User
1 day ago
Absolutely flawless work!
👍 241
Reply
4
Marielly
Engaged Reader
1 day ago
This is one of those “too late” moments.
👍 289
Reply
5
Bacilio
Registered User
2 days ago
Pullbacks in select sectors provide rotation opportunities.
👍 209
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.